Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

ELOVL1-IN-1

ELOVL1-IN-1
ELOVL1-IN-1 (1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide) is an ELOVL1 inhibitor. ELOVL1-IN-1 can reduce the levels of very long chain fatty acids. ELOVL1-IN-1 can be used in the study of adrenoleukodystrophy (ALD).
Catalog No. T9578Cas No. 2227482-41-7
Select Batch
Purity:98.55%
Contact us for more batch information
Resource Download

ELOVL1-IN-1

Catalog No. T9578Cas No. 2227482-41-7
ELOVL1-IN-1 (1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide) is an ELOVL1 inhibitor. ELOVL1-IN-1 can reduce the levels of very long chain fatty acids. ELOVL1-IN-1 can be used in the study of adrenoleukodystrophy (ALD).
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$136In Stock
5 mg$338In Stock
10 mg$497In Stock
25 mg$890In Stock
50 mg$1,270In Stock
100 mg$1,650In Stock
1 mL x 10 mM (in DMSO)$386In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "ELOVL1-IN-1"

Product Introduction

Bioactivity
Description
ELOVL1-IN-1 (1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide) is an ELOVL1 inhibitor. ELOVL1-IN-1 can reduce the levels of very long chain fatty acids. ELOVL1-IN-1 can be used in the study of adrenoleukodystrophy (ALD).
In vitro
Administration of 1 nM-10 μM ELOVL1-IN-1 for 48 h reduces the level of VLCFA, lysophosphatidylcholine (LPC) in adrenoleukodystrophy (ALD) patient fibroblasts and healthy human fibroblasts, ALD patient B‐lymphocytes, and human microglia[1].
In vivo
Oral dministration of ELOVL1-IN-1 reduces of a VLCFA level, specifically C26:0 LPC level in blood of ABCD1 knockout mice (0.5-64 mg/kg; 28 days), wild‐type (WT) rats (30-300 mg/kg; 7 days), and cynomolgous monkeys (30 mg/kg; 7 days)[1].
Alias1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide
Chemical Properties
Molecular Weight340.33
FormulaC18H14F2N4O
Cas No.2227482-41-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (146.92 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9383 mL14.6916 mL29.3832 mL146.9162 mL
5 mM0.5877 mL2.9383 mL5.8766 mL29.3832 mL
10 mM0.2938 mL1.4692 mL2.9383 mL14.6916 mL
20 mM0.1469 mL0.7346 mL1.4692 mL7.3458 mL
50 mM0.0588 mL0.2938 mL0.5877 mL2.9383 mL
100 mM0.0294 mL0.1469 mL0.2938 mL1.4692 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ELOVL1-IN-1 | purchase ELOVL1-IN-1 | ELOVL1-IN-1 cost | order ELOVL1-IN-1 | ELOVL1-IN-1 chemical structure | ELOVL1-IN-1 in vivo | ELOVL1-IN-1 in vitro | ELOVL1-IN-1 formula | ELOVL1-IN-1 molecular weight